THORASYS Thoracic Medical Systems Inc.

We introduce fast, easy point-of-care diagnostics to pulmonary medicine and provide unique insight into critically important small airway function.

  • Stage $500K in TTM Revenue
  • Industry Medical Devices and Equipment
  • Location Montreal, QC, Canada
  • Currency CAD
  • Founded June 2007
  • Employees 4
  • Website thorasys.com

Company Summary

Lung diseases affect ~600M people worldwide. The total cost to the US economy exceeds $180B p.a., yet there is a profound lack of fast, easy point-of-care diagnostics. Our patented technology fills this gap, providing rapid, effortless lung function assessment and unique insights into diagnostically highly important "small airways". Our tremoFlo C-100 AOS is approved and selling in Europe, Canada and Australia. We expect our 510(k) in early 2016.

Team

  • Founder, President & CEO

    Ph.D. in Biomedical Engineering, McGill 1997; Co-founder & President of SCIREQ Inc. 1997-2014

  • Founder, Chief Scientific Advisor

    Ph.D. in Biomedical Engineering, McGill;
    Post-Doc at Harvard University;
    Professor and Director of Department of Biomedical Engineering, Dalhousie University

  • Vice President, Operations & Regulatory Affairs

    M.Eng. in Engineering Management, Université de Sherbrooke;
    B.Eng. in Mechanical Engineering, École Polytechnique de Montréal

  • Yvan Beaudoin
    CEO

Advisors

  • Michel Brunet, Dentons, Montreal
    Lawyer
    Unconfirmed
    Lawrence Chandler, Nexia Friedman, Montreal
    Accountant
    Unconfirmed

Previous Investors

  • Atlantic Canada Opportunities Agency
    Unconfirmed
    Innovacorp
    Unconfirmed
    Internal/Friends & Family
    Unconfirmed

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free